Positive Selection System to Screen for Inhibitors of Human Immunodeficiency Virus-1 Transcription

Nature Biotechnology

Volumn 14, Issue 11, 1996, Pages 1592-1596

  Del Rosario, Merci ^a   Stephans, James C ^a   Zakel, Joan ^a   Escobedo, Jaime ^a   Giese, Klaus ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

HIV 1; Tat protein; Transcription based drug screening

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL ACTIVITY; CYTOMEGALOVIRUS; DRUG SCREENING; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVIEW; TRANSCRIPTION REGULATION; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

ALKALINE PHOSPHATASE; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE PRODUCTS, TAT; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HELA CELLS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; ISOENZYMES; PLASMIDS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE INHIBITORS; TRANSCRIPTION, GENETIC;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 10344228272     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1196-1592     Document Type: Article

References (32)

1. Cullen, B.R. and Greene, W.C. 1989. Regulatory pathways governing HIV-1 replication. Cell 58:423-426.
2. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
3. Roulston, A., Lin, R., Beauparlant, P., Wainberg, M.A., and Hiscott, J. 1995. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myoloid cells by NF-kB/Rel transcription factors. Microbiol. Rev. 59:481-505.
4. Selby, M.J., Bain, E.S., Luciw, P.A., and Peterlin, B.M. 1989. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558.
5. Sharp, P.A. and Marciniak, R.A. 1989. HIV TAR: an RNA enhancer? Cell 59:229-230.
6. Marciniak, R.A., Garcia-Blanco, M.A., and Sharp, RA. 1990. Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-responsive TAT element RNA. Proc. Natl. Acad. Sci. USA 87:3624-3628.
7. Wu, R, Garcia, J., Sigman, D., and Gaynor, R. 1991. Tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding TRP-185. Genes Dev. 5:2128-2140.
8. Sheline, C., Milocco, L.H., and Jones, K. 1991. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:2508-2520.
9. Mhashilkar, A.M., Bagley, J., Chen, S.Y., Szilvay, A.M., Helland, D.G., and Marasco, W.A. 1995. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14:1542-1551.
10. Rice, W.G., Supko, J.G., Malspeis, L, Buckheit Jr., R.W., Clanton, D., Bu, M., et al. 1995. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270:1194-1197.
11. Hsu, M.-C, Schutt, A.D., Holy, M., Slice, L.W., Sherman, M.I., Richman, D.D., et al. 1991. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science 254:1799-1802.
12. Hsu, M.-C, Dhingra, U., Earley, J.V., Holly, M., Keith, D., Nalin, CM., et al. 1993. Inhibition of type 1 human immunodeficiency virus replication by a Tat antagonist to which the virus remains sensitive after prolonged exposure in vitro. Proc. Natl. Acad. Sci. USA 90:6395-6399.
13. Sarver, N., Black, R.J., Bridges, S., and Chrisey, L. 1992. Frontiers in HIV-1 therapy: Fourth conference of the NIAID national cooperative drug discovery groups-HIV. AIDS Res. Hum. Retroviruses 8:659-666.
14. Witvrouw, W., Pauwels, R., Vandamme, A.-M., Schols, D., Reymen, D., Yamamoto, N., et al. 1992. Cell type-specific anti-human immunodeficiency virus type I activity of the transactivation inhibitor Ro5-3335. Antimicrob. Agents Chemothr. 36:2628-2633.
15. Feinberg, M.B., Baltimore, D., and Frankel, A.D. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88:4045-4049.
16. Cullen, B.R. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
17. Kao, S.-Y, Calman, A.F., Luciw, P.A., and Peterlin, B.M. 1987. Antltermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-493.
18. Greenblatt, J., Nodwell, J.R., and Mason, S.W. 1993. Transcriptional antitermination. Nature 364:401-406.
19. Zenzie-Gregory, B., Sheridan, P., Jones, K.A., and Smale, S.T. 1993. HIV-1 core promoter lacks a simple initiator element but contains bipartite activator at the transcription start site. J. Biol. Chew. 268:15823-15832.
20. Rittner, K., Churcher, M.J., Gait, M.J., and Karn, J. 1995. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J. Mol. Biol. 562:562-580.
21. Izant, J.G. and Weintraub, H. 1994. Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis. Cell 36:1007-1015.
22. Wagner, R.W. 1994. Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335.
23. Sullenger, B.A., Gallardo, H.F., Lingers, G.E., and Gilboa, E. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601-608.
24. Graham, G.J. and Maio, J.J. 1991. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral trans-activator. Proc. Natl. Acad. Sci. USA 87:5817-5821.
25. Jones, K.A. and Peterlin, B.M. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
26. Wang, J.C. 1991. DNA topoisomerases: why so many? J. Biol. Chem. 266:6659-6662.
27. Matthias, P., Mueller, M., Schreiber, E., Rusconi, S., and Schaffner, W. 1989. Eukaryotic expression vectors for the analysis of mutant proteins. Nucleic Acids Res. 17:6418-6418.
28. Sanchez-Pescador, R., Power, M.D., Barry, P.J., Stimer, K.S., Stempien, M.M., Brown-Shimer, S.L., et al. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484-492.
29. Ogawa, E., Maruyama, M., Kagoshima, R, Inuzuka, M., Lu, J., Satake, M., et al. 1993.PEBP2α/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AMU gene. Proc. Natl. Acad. Sci. USA 90:6859-6863.
30. Takebe, Y, Seiki, M., Fijisawa, J., Hoy, P., Yokota, K., Arai, K., et al. 1988. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466-472.
31. Zhang, Y, Proenca, R., Maffei, M., Barone, M., Leopold, L, and Friedman, J.M. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432.
32. Giese, K. and Grosschedl, R. 1993. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 12:4667-4676.